The NHS says it knows some people are getting hold of retatrutide for weight loss and reminds them the trial drug has no license or approval.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
The doctor says drugs like semaglutide can curb appetite, and argues people should also learn how the body burns fat on its own.
GLP-1 drugs help with weight loss and diabetes care. Doctors are telling patients that losing weight quickly on them may also reduce muscle and bone.
Loading…